ERIKA SEARCY: Open Payments
NPI 1790468858 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,090 in 25 payments from 12 companies in 2025. Trend: 2023 $83 · 2024 $1,225 · 2025 $1,090
Food & beverage: $1,010Education: $80
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $352 |
| ABBVIE INC. | 4 | $145 |
| Lilly USA, LLC | 2 | $138 |
| Amgen Inc. | 1 | $116 |
| AstraZeneca Pharmaceuticals LP | 1 | $77 |
| GENZYME CORPORATION | 1 | $71 |
| E.R. Squibb & Sons, L.L.C. | 2 | $47 |
| Organogenesis Inc. | 3 | $45 |
| UCB, Inc. | 2 | $33 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $28 |
Products named: TREMFYA, SKYRIZI, REPATHA, WAINUA, DUPIXENT, Sotyktu, Bimzelx, VIA MATRIX.
Industry payments across AL — which companies pay providers there.
